Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8495)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2015 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang J, Zuo CJ, Jia NY, Wang JH, Hu SP, Yu ZF, Zheng Y, Zhang AY, Feng XY. Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer. World J Gastroenterol 2015; 21(10): 2988-2996 [PMID: 25780297 DOI: 10.3748/wjg.v21.i10.2988] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i10/2988.htm |
| Number | Citing Articles |
| 1 |
Lucy Oldfield, Rohith Rao, Lawrence N. Barrera, Eithne Costello. Pancreatic Cancer. 2018; : 1241 doi: 10.1007/978-1-4939-7193-0_86
|
| 2 |
Shengyun Huang, Huanhuan Chong, Xun Sun, Zhijian Wu, Qing Jia, Yongxue Zhang, Xiaoli Lan. The Value of 18F-FDG PET/CT in Diagnosing Pancreatic Lesions: Comparison With CA19-9, Enhanced CT or Enhanced MR. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.668697
|
| 3 |
Kelly Trinh, David Z. Chow, Hyesun Park, Ukasha Habib, Lily Offit, Elisa Franquet, Renata R. Almeida, Yingbing Wang, Nuno Borges, Faisal Jamal, Heather A. Jacene, Pedram Heidari, Thomas S.C. Ng. Evaluating the added value of concurrent contrast-enhanced diagnostic CT for PSMA-PET/CT Interpretation. Academic Radiology 2024; doi: 10.1016/j.acra.2024.08.008
|
| 4 |
Francisco Sánchez-Bueno, Rocío García-Pérez, María Antonia Claver Valderas, Jesús de la Peña Moral, Laura Frutos Esteban, Eduardo Ortiz Ruiz, Matilde Fuster Quiñonero, Pascual Parrilla Paricio. Utility of 18 Fludeoxyglucose in Preoperative Positon-Emission Tomography-Computed Tomography (PET-CT) in the Early Diagnosis of Exocrine Pancreatic Cancer: A Study of 139 Resected Cases. Cirugía Española (English Edition) 2016; 94(9): 511 doi: 10.1016/j.cireng.2016.11.006
|
| 5 |
Zheng Yuan, Jian Zhang, Huan Yang, Xiao-Dan Ye, Li-Chao Xu, Wen-Tao Li. Diffusion-Weighted MR Imaging of Hepatocellular Carcinoma: Current Value in Clinical Evaluation of Tumor Response to Locoregional Treatment. Journal of Vascular and Interventional Radiology 2016; 27(1): 20 doi: 10.1016/j.jvir.2015.10.003
|
| 6 |
Siyang Wang, Hongcheng Shi, Feixing Yang, Xinyu Teng, Bo Jiang. The value of 18F-FDG PET/CT and carbohydrate antigen 19-9 in predicting lymph node micrometastases of pancreatic cancer. Abdominal Radiology 2019; 44(12): 4057 doi: 10.1007/s00261-019-02248-0
|
| 7 |
Heying Duan, Lucia Baratto, Andrei Iagaru. The Role of PET/CT in the Imaging of Pancreatic Neoplasms. Seminars in Ultrasound, CT and MRI 2019; 40(6): 500 doi: 10.1053/j.sult.2019.04.006
|
| 8 |
Michele Ghidini, Marta Vuozzo, Barbara Galassi, Paola Mapelli, Virginia Ceccarossi, Lucio Caccamo, Maria Picchio, Daniele Dondossola. The Role of Positron Emission Tomography/Computed Tomography (PET/CT) for Staging and Disease Response Assessment in Localized and Locally Advanced Pancreatic Cancer. Cancers 2021; 13(16): 4155 doi: 10.3390/cancers13164155
|
| 9 |
L. Wang, P. Dong, W.G. Wang, B.L. Tian. Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysis. International Journal of Surgery 2017; 46: 119 doi: 10.1016/j.ijsu.2017.09.003
|
| 10 |
G. E. Roitberg, O. Yu. Anikeeva. PET-CT monitoring in the treatment of pancreatic cancer. South Russian Journal of Cancer 2020; 1(4): 54 doi: 10.37748/2687-0533-2020-1-4-7
|
| 11 |
Francisco Sánchez-Bueno, Rocío García-Pérez, María Antonia Claver Valderas, Jesús de la Peña Moral, Laura Frutos Esteban, Eduardo Ortiz Ruiz, Matilde Fuster Quiñonero, Pascual Parrilla Paricio. Utilidad de la 18-fluorodeoxiglucosa en la tomografía por emisión de positrones-tomografía computarizada (PET-TC) preoperatoria en el diagnóstico precoz del cáncer de páncreas exocrino: estudio en 139 casos resecados. Cirugía Española 2016; 94(9): 511 doi: 10.1016/j.ciresp.2016.07.007
|
| 12 |
Jing Yang, Sainan Li, Jingjing Li, Fan Wang, Kan Chen, Yuanyuan Zheng, Jianrong Wang, Wenxia Lu, Yuqing Zhou, Qin Yin, Huawei Zhang, Chuanyong Guo. A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancer. Pancreatology 2016; 16(4): 605 doi: 10.1016/j.pan.2016.04.033
|
| 13 |
Domenico Tamburrino, Deniece Riviere, Mohammad Yaghoobi, Brian R Davidson, Kurinchi Selvan Gurusamy. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database of Systematic Reviews 2016; 2016(9) doi: 10.1002/14651858.CD011515.pub2
|
| 14 |
O. P. Shesternikova, V. K. Finn, K. A. Lesko, L. V. Vinokurova. Intelligent System for Predicting the Feasibility of Using Computed Tomography. Scientific and Technical Information Processing 2023; 50(5): 464 doi: 10.3103/S0147688223050131
|
| 15 |
Farshad Moradi, Andrei Iagaru. The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer. Seminars in Nuclear Medicine 2020; 50(5): 434 doi: 10.1053/j.semnuclmed.2020.04.002
|
| 16 |
Shuli Yang, Ruixue Ma, Jing Wu. The diagnostic value of combining preoperative serum CA19-9, ALBI score, and 18F-FDG PET/CT imaging in preoperative resectability of pancreatic cancer. Nuclear Medicine Communications 2024; 45(12): 1061 doi: 10.1097/MNM.0000000000001910
|
| 17 |
Paula Ghaneh, Robert Hanson, Andrew Titman, Gill Lancaster, Catrin Plumpton, Huw Lloyd-Williams, Seow Tien Yeo, Rhiannon Tudor Edwards, Colin Johnson, Mohammed Abu Hilal, Antony P Higginson, Tom Armstrong, Andrew Smith, Andrew Scarsbrook, Colin McKay, Ross Carter, Robert P Sutcliffe, Simon Bramhall, Hemant M Kocher, David Cunningham, Stephen P Pereira, Brian Davidson, David Chang, Saboor Khan, Ian Zealley, Debashis Sarker, Bilal Al Sarireh, Richard Charnley, Dileep Lobo, Marianne Nicolson, Christopher Halloran, Michael Raraty, Robert Sutton, Sobhan Vinjamuri, Jonathan Evans, Fiona Campbell, Jon Deeks, Bal Sanghera, Wai-Lup Wong, John P Neoptolemos. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. Health Technology Assessment 2018; 22(7): 1 doi: 10.3310/hta22070
|
| 18 |
Lucy Oldfield, Rohith Rao, Lawrence N Barrera, Eithne Costello. Pancreatic Cancer. 2017; : 1 doi: 10.1007/978-1-4939-6631-8_86-1
|
| 19 |
Lawrence MJ Best, Vishal Rawji, Stephen P Pereira, Brian R Davidson, Kurinchi Selvan Gurusamy. Imaging modalities for characterising focal pancreatic lesions. Cochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD010213.pub2
|
| 20 |
M Jones, S Higgs, S Dwerryhouse, V Markos, K Mason, C Green, A Nawwar, J Searle, I Lyburn. Combined positron emission tomography and contrast enhanced CT (PET/CeCT) is a feasible single investigation in the staging of oesophagogastric cancers: single-centre pilot study experience during the COVID-19 pandemic. The Annals of The Royal College of Surgeons of England 2024; 106(7): 576 doi: 10.1308/rcsann.2023.0070
|
| 21 |
Gilles Metrard, Clara Cohen, Matthieu Bailly. Comprehensive literature review of oral and intravenous contrast-enhanced PET/CT: a step forward?. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1373260
|
| 22 |
Piotr Hogendorf, Aleksander Skulimowski, Adam Durczyński, Anna Kumor, Grażyna Poznańska, Aleksandra Oleśna, Joanna Rut, Janusz Strzelczyk. A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/8629712
|
| 23 |
Jeffrey H. Lee, Lisa S. Cassani, Priya Bhosale, William A. Ross. The endoscopist’s role in the diagnosis and management of pancreatic cancer. Expert Review of Gastroenterology & Hepatology 2016; 10(9): 1027 doi: 10.1080/17474124.2016.1176910
|
| 24 |
Jing Zhang, Jiali Zhang, Jing Han. Advantages and clinical significance of enhanced CT combined with BRAF V600E gene detection in the diagnosis of papillary thyroid carcinoma. Medical Engineering & Physics 2022; 110: 103862 doi: 10.1016/j.medengphy.2022.103862
|
| 25 |
H. Duan, L. Baratto, R. Laudicella, F. Stracuzzi, S. Baldari, A. Iagaru. Molecular imaging of pancreatic neoplasms. Clinical and Translational Imaging 2021; 9(2): 141 doi: 10.1007/s40336-020-00408-7
|
| 26 |
LIANG LIU, JINFENG XIANG, RUFU CHEN, DELIANG FU, DEFEI HONG, JIHUI HAO, YIXIONG LI, JIANGTAO LI, SHENGPING LI, YIPING MOU, GANG MAI, QUANXING NI, LI PENG, RENYI QIN, HONGGANG QIAN, CHENGHAO SHAO, BEI SUN, YONGWEI SUN, MIN TAO, BOLE TIAN, HONGXIA WANG, JIAN WANG, LIWEI WANG, WEI WANG, WEILIN WANG, JUN ZHANG, GANG ZHAO, JUN ZHOU, XIANJUN YU. The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC). International Journal of Oncology 2016; 48(3): 900 doi: 10.3892/ijo.2015.3316
|